Metis Global Partners, LLC Teva Pharmaceutical Industries LTD Transaction History
Metis Global Partners, LLC
- $3.16 Billion
- Q3 2024
A detailed history of Metis Global Partners, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Metis Global Partners, LLC holds 12,837 shares of TEVA stock, worth $292,298. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,837
Previous 12,478
2.88%
Holding current value
$292,298
Previous $202,000
14.36%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TEVA
# of Institutions
625Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$979 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$825 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$787 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$657 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$603 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $25.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...